Single-Dose Psilocybin Treatment for Major Depressive Disorder

This randomized clinical trial examines the timing of onset of action, durability of benefit, and safety profile of single-dose psilocybin in patients with majo

Related Keywords

United States ,Berkeley ,California ,American ,Williama Linton ,Blake Mycoskie ,Craig Nerenberg ,Alexandra Cohen ,Clexio Biosciences ,Matt Mullenweg ,Neurocrine Biosciences ,Denovo Biopharma ,Bristol Myers Squibb ,Tim Ferriss ,Sage Pharmaceuticals ,Promega Corporation ,Usona Institute ,Usona Institute Inc ,Noven Pharmaceuticals ,Fournier Family Foundation ,Public Benefit Corporation ,Alexander Shulgin Research Institute ,Lundbeck ,Johns Hopkins Center ,Gilgamesh Pharmaceuticals ,Tiny Blue Dot Foundation ,Alexandra Cohen Foundation ,Research Allocation Program ,Multidisciplinary Association Of Psychedelic ,Council On Spiritual Practices ,Nrx Pharmaceuticals ,Semmes Company Inc ,Turnbull Family Foundation ,Navitor Pharmaceuticals ,National Institute On Drug Abuse ,Novartis ,York University Grossman School Of Medicine ,Ambershore Group ,American Center ,Silo Pharmaceuticals ,Hopkins Center ,Drug Administration ,Multidisciplinary Association For Psychedelics ,Heffter Research Institute ,Cylerity Corporation ,National Cancer Institute ,Noetic Fund ,Seelos Pharmaceuticals ,Concord Health ,Travistock Company ,Vail Health ,Consciousness Research ,Biohaven Pharmaceuticals ,Filament Health ,Yale University ,Berkeley Center ,California Institute For Integral ,Promega Corporation Life Science ,Taisho Pharmaceuticals ,Department Of Defense ,Institutional Review Board Copernicus Group ,Boehringer Ingelheim ,Statistical Manual ,Mental Disorders ,Fifth Edition ,Montgomery Asberg Depression Rating Scale ,Sheehan Disability Scale ,Design Overview ,International Conference ,Harmonization Good Clinical Practice ,Structured Clinical Interview ,Ethnicity Data ,Clinical Global Impressions Scale ,Hamilton Anxiety Rating Scale ,Life Enjoyment ,Satisfaction Questionnaire ,Major Depressive Disorder Scale ,Oxford Depression Questionnaire ,Columbia Suicide Severity Rating Scale ,Drs Raison ,Interest Disclosures ,Good Ventures ,Emory Healthcare ,Axsome Therapeutics ,Engrail Therapeutics ,Intra Cellular Therapies ,Levo Therapeutics ,Perception Neuroscience ,Praxis Therapeutics ,Relmada Therapeutics ,Vistagen Therapeutics ,Freedom Biosciences ,Allocation Program ,Boxer Capital ,Compass Pathways ,Cerebral Therapeutics ,Myriad Neuroscience ,Alto Neuroscience ,Benefit Corporation ,Multidisciplinary Association ,Psychedelics Studies ,North American Center ,Continuing Medical Education ,California Institute ,Integral Studies ,Numinus Wellness ,Psychedelic Studies Public Benefit Corp ,Healthbridge Financial ,Psychedelic Medicines ,Life Science ,National Institute ,Drug Abuse ,Spiritual Practices ,Psychedelic Studies ,Reset Pharmaceuticals ,New York University Grossman School ,Good Manufacturing Practice ,Emmes Company ,